Late-Life Gene Therapy Extends Lifespan and Healthspan in Aging Mice
A groundbreaking study shows late-life gene therapy targeting FGF21 significantly boosts lifespan and health markers in male mice, offering new avenues for healthy aging.
A groundbreaking study shows late-life gene therapy targeting FGF21 significantly boosts lifespan and health markers in male mice, offering new avenues for healthy aging.